friday report ep slightli ahead consensu estim
top bottom line rais sales/ep guidanc low end base
stabil manufactur suppli salesforc increas confid
stabil manag move forward goal grow within weight
averag market growth six month vs previous
driver ahead includ rosa robot knee system cementless knee launch
increas traction special saleforc manag also take
advantag lower expect tax rate reinvest commerci
organ higher growth area assum anyth near-term
tuck-in anoth new opportun bolster faster grow segment
sale comment us knee acceler includ
rosa placement manag indic underli growth also narrow gap
market saw sequenti acceler spine came
light comp tougher manag believ salesforc consolid
larg behind rosa spine launch vs assum
improv
note oper margin also better think higher
gross margin better sg leverag remind loss bone cement
distribut contract impact sale anniversari knee/hip
market days-adjust growth jnj/syk/zbh market increas
base estim despit slightli tougher comp
knee rosa placement far still modest earli stage
launch feedback posit manag note
increas invest rosa commerci organ on-going persona
cementless knee anoth area organiz focu rosa cementless
guidanc sale guidanc rais low-end flat
despit higher assum fx headwind vs
previous ep guid rais top-end oper
margin guidanc lower commerci
organ particularli rosa reinvest tax rate expect
vs previous
estim sales/ep bump higher constant currenc
sale estim rise
ep remain use cash would upsid estim
recent peer multipl expans price target rise
year price histori
manufactur
distribut orthoped dental
trauma product relat surgic
analyst certif import disclosur see disclosur
underli sale growth improv full year sale growth
almost
free cash flow use paydown debt guidanc
sg leverag begin build signific impact yet
suppli chain effici work
trade discount large-cap peer
price-to-earnings key mileston look forward zimmer shift
focu improv suppli cost reduct initi
continu build-out special salesforc new
product launch led robot knee spine system knee
on-going spine key launch includ
persona cementless full launch underway revis
persona cementless on-going revis knee launch
launch rosa knee spine
quicker share recaptur improv suppli
faster acceler busi outsid large-joint ortho
use growth enhanc tuck-in
neg respons fda warn letter respons
slower expect hip/kne market growth
greater expect impact competitor rollout
price target driven blend discount cash flow compar pe analysi dcf use weight
averag cost capit wacc termin growth rate estim ebitda target impli
price-to-earnings multipl ep
risk price target includ wors expect price pressur key market declin procedur macro headwind
greater expect impact competitor rollout
includ expect one-tim gross margin benefit revers previou med-tech tax accrual bp estim posit impact
stock price compani mention report
